Diseases Archives - Page 23 of 43 - Pharma Journalist

DreaMed Diabetics attained CE Mark for Platform tackling Type 1 diabetes

Evofem Biosciences completes enrollment in Phase 3 Clinical Trial for Amphora

Citius enrolls first patient in Mino-Lok Phase 3 Clinical trial

Eisai asserts positive results of Phase 3 Study for lenvatinib mesylate

Merck KGaA and Pfizer assert Phase III JAVELIN Lung 200 trial results

Tusker Medical enlists first patient for OTTER Study

Servier and ImmunoQure partner to advance human Interferon-α autoantibody

Spineology finishes enrollment in IDE Trial for Mesh Fusion Transplant

FDA concedes Glooko’s Mobile Insulin Dosing System

IRX Therapeutics commences Phase 2 Clinical Trial for CIN3 or VIN3 women